Syntara Limited has released a press release.
Pharmaxis Appoints Chiesi as Bronchitol Distributor in Italy
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Syntara
- Appendix 4C - quarterly cash flow
- Quarterly Shareholder Update March 2017
- Synairgen Collaboration Progress
- Chairmans Address to Shareholders
- Research Collaboration with Woolcock Institute
Later from Syntara
- Pharmaxis Set to Generate Further Euro 10m Milestone Payment
- Pharmaxis Announces Results of Pivotal CF Clinical Trial
- Appendix 4C - quarterly June 2017
- Preliminary Final Report June 2017
- Positive Recommendation for Broader Bronchitol Access in Aus
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara